Innovations

Latest KFF Health News Stories

KFF Health News' 'What the Health?': The Crisis Is Officially Ending, but Covid Confusion Lives On

Podcast

The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.

How One Patient’s Textured Hair Nearly Kept Her From a Needed EEG

KFF Health News Original

An EEG can help diagnose conditions like epilepsy, sleep disorders, and brain tumors. But a design flaw and outdated Eurocentric practices make the test less effective on thicker, denser, and curly hair types, potentially excluding or deterring some people from getting screened.

Listen: How Does Human Composting Work?

KFF Health News Original

California Healthline’s Bernard J. Wolfson went on the air to explain a new California law that will allow people to have their bodies reduced to compost after death, an alternative to the traditional-but-toxic methods of cremation and burial.

Addressing the ‘Trust Factor’: South Carolina Researchers Tackle Health Disparities Using Genetics

KFF Health News Original

A new genetic research project underway in South Carolina aims to reduce health disparities between Black and white residents — such as cancer and cardiovascular disease rates — that have long ranked among the nation’s worst. But researchers face the challenge of recruiting 100,000 participants who reflect the diversity of South Carolina. And history isn’t on their side.